secwatch.observer — SEC 8-K summary
======================================

Issuer:     Enveric Biosciences, Inc. (ENVB)
CIK:        0000890821
Form:       8-K
Filed at:   2021-11-18T23:59:59+00:00
Accession:  0001493152-21-029223
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Enveric Biosciences appoints Avani Kanubaddi as President, lowers quorum to one-third
--------------------------------------------------------------------------------

- Avani Kanubaddi, current COO since Dec 2020, appointed President effective Nov 15, 2021.
- Board approved amendment to bylaws reducing stockholder quorum from majority to one-third.
- Kanubaddi previously COO at NEXGEL and founder of Welmedix Healthcare.
- Amendment is effective Nov 15, 2021; full text filed as Exhibit 3.1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/890821/000149315221029223/0001493152-21-029223-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/890821/000149315221029223/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-21-029223

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer